Clear or slightly opalescent from colorless to light brown liquid.
Each mL of concentrate contains: Bevacizumab 25 mg corresponding to 1.4 to 16.5 mg/mL when diluted as recommended.
Each 4 mL vial contains: Bevacizumab 100 mg corresponding to 1.4 mg/mL when diluted as recommended.
Each 16 mL vial contains: Bevacizumab 400 mg corresponding to 16.5 mg/mL when diluted as recommended.
Excipients/Inactive Ingredients: The other ingredients are trehalose dihydrate, sodium phosphate, polysorbate 20 and water for injections.
Other Services
Country
Account